PROCEPT BioRobotics Corporation — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $76M | ↑+11.9% | — | — | — |
| 2025-09-30 | $83M | ↑+42.8% | $-21M | ↓-2.1% | -27.8% |
| 2025-06-30 | $79M | ↑+48.4% | $-20M | ↑+23.6% | -28.0% |
| 2025-03-31 | $69M | ↑+55.3% | $-25M | ↑+4.7% | -39.7% |
| 2024-12-31 | $68M | ↑+56.6% | — | — | — |
| 2024-09-30 | $58M | ↑+66.3% | $-21M | ↑+14.8% | -38.4% |
| 2024-06-30 | $53M | ↑+61.2% | $-26M | ↓-1.3% | -50.3% |
| 2024-03-31 | $45M | ↑+82.5% | $-26M | ↑+8.9% | -62.1% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 24 quarters
margin trajectory tells the operating-leverage storyGo deeper
PRCT Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyPRCT Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics